SCHEMBL7708458

SCHEMBL7708458

COc1ncc(Oc2ccccc2)c(=O)[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.51
▸ LMNA P02545 3/20 0.44
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ HTT P42858 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ KDM4C Q9H3R0 1/20 0.43
▸ BRD4 O60885 4/20 0.40
▸ NTRK1 P04629 1/20 0.39
▸ IGF1R P08069 1/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ NTRK2 Q16620 1/20 0.39
▸ LTA4H P09960 1/20 0.39
▸ CSNK1A1 P48729 1/20 0.38
▸ CSNK1D P48730 1/20 0.38
▸ CSNK1G2 P78368 1/20 0.38
▸ TTR P02766 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5206240 0.78 NOS1 (0.45) RECQLLMNAKDM4CBRD4LTA4H
SCHEMBL11603668 0.74 KDM4C (0.48) KDM4CBRD4LTA4H
SCHEMBL7712501 0.72 XDH (0.45) RECQLLMNAL3MBTL1SMN1; SMN2HTT
SCHEMBL7712389 0.71 MAPT (0.49) RECQLLMNAL3MBTL1SMN1; SMN2HTT
SCHEMBL3971478 0.69 ALDH1A1 (0.46) RECQLLMNAL3MBTL1SMN1; SMN2HTT
SCHEMBL15614429 0.68 RECQL (1.00) RECQLLMNAL3MBTL1SMN1; SMN2HTT
SCHEMBL7714251 0.68 HTT (0.50) RECQLLMNAL3MBTL1SMN1; SMN2HTT
SCHEMBL14019141 0.67 BRD4 (0.39) BRD4NTRK1IGF1RFGFR1NTRK2
SCHEMBL17959988 0.67 LTA4H (0.51) KDM4CBRD4LTA4H
SCHEMBL11439501 0.66 ALDH1A1 (0.50) LMNAL3MBTL1HTTBRD4LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 — — US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 — — EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 — — WO disclosed
Send feedback